Group items tagged

The UK Health Security Agency (UKHSA) and the Office for National Statistics (ONS) will jointly launch a new study to gather data on COVID-19 this winter. The Winter COVID-19 Infection Study (WCIS) will run from November 2023 to March 2024, involving up to 200,000 participants, UKHSA has said on Monday (October 2). UKHSA previously commissioned the Coronavirus Infection Survey (CIS), conducted by the ONS in collaboration with scientific study leaders from Oxford University, analysing more than 11.5 million swab tests and 3 million blood tests from April 2020 to March 2023. Meanwhile, the Winter CIS study involves conducting up to 32,000 lateral flow tests weekly, providing vital insights into COVID-19 prevalence in the broader community. The sample will be structured to broadly reflect key population characteristics.

Community Pharmacy England (CPE) is organising a series of webinars to help pharmacy owners and their teams to prepare for the implementation of new Pharmacy First service, and changes to the Contraception and Hypertension Case-Finding Services. Beginning from 5th December, the webinars would be conducted throughout December and January, with support from NHS England and the Centre for Postgraduate Education (CPPE), the organisation announced on Thursday (30 November). During the online seminars, pharmacy teams will be explained about the individual services announced, and things to consider before they start providing, or expand their offering of, these services. Each webinar will have CPE's Services Team, who would be leading the team, and policy experts from NHS England and CPPE as speakers.

From April 2022, contractors will have to make all monthly FP34C submissions only through the Manage Your Service (MYS) portal, the Pharmaceutical Services Negotiating Committee (PSNC) said in an update. This will be for prescriptions dispensed from March 2022. The last paper FP34C submission document will be posted out to contractors this month. Contractors who have not yet registered for MYS, can do so by completing the form on the NHSBSA's website. While encouraging contractors to switch to the MYS, the negotiator stated that nearly 1,500 pharmacy contractors still depend on the paper FP34C submission document.

Governments should invest in vaccines for all strains of influenza virus that exist in the animal kingdom as an insurance policy in case of an outbreak in humans, the incoming chief scientist at the World Health Organization said on Monday (Feb. 20). Countries ranging from the United States and Britain to France and Japan have suffered record losses of poultry in outbreaks of avian flu in the past year. The recent spread to mammals of H5N1 - commonly known as bird flu - needed to be monitored, but the risk to humans remained low, the WHO said earlier this month. Incoming WHO chief scientist Jeremy Farrar said he would like to see the pharmaceutical industry at least conduct some clinical trials for all influenza strains such that the world would not have to start from scratch to initiate global manufacturing should the need arise. "My concern that we're in slow motion watching something which may never happen," he added in a media briefing. "But if it were to happen, would we look back on what we're doing at the moment and say, why didn't we do more?"

Explore the innovations in mental health care through our online cme live webinar. Intended for Psychiatrists, Psychologists, Primary Care physicians and nurses. where we explore the forefront of advanced therapies and integrative approaches in mental health treatment. This event, scheduled for May 09, 2024, brings together experts and pioneers in the field to share insights on groundbreaking strategies.